Dec 1, 2025 Log in

調查

Lotus Pharmaceutical Co., Ltd. (1795) Reports Strong Q4 2025 Earnings with EPS of NT$18.14

Citation-Grade Primary-source linked Schema.org verified NQ 65 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published Dec 1, 2025 9:00 AM ・ Updated Jun 13, 2026 11:49 PM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

Lotus Pharmaceutical Co., Ltd.
(1795) announced its fourth quarter 2025 financial results, reporting a basic earnings per share (EPS) of NT$18.14.
The company achieved quarterly revenue of NT$20.509 billion and a net profit after tax of NT$4.720 billion, solidifying its position as a leading company in Taiwan's biotechnology and healthcare sector.

Lotus Pharmaceutical Co., Ltd. (1795) announced its fourth quarter 2025 financial results, reporting a basic earnings per share (EPS) of NT$18.14. The company achieved quarterly revenue of NT$20.509 billion and a net profit after tax of NT$4.720 billion, solidifying its position as a leading company in Taiwan's biotechnology and healthcare sector.

PRIMARY SOURCE PR Times View source Distributor: PR Times
Published: Dec 1, 2025

Lotus Pharmaceutical Co., Ltd., trading under the stock code 1795, has released its financial report for the fourth quarter of 2025. The company, a prominent player in Taiwan's biotechnology and healthcare industry, reported a robust basic earnings per share (EPS) of NT$18.14 for the quarter.

During the fourth quarter of 2025, Lotus Pharmaceutical generated operating revenue amounting to NT$20.509 billion. The net profit after tax for the same period reached NT$4.720 billion.

Company Code: 1795 Company Name: Lotus Pharmaceutical Co., Ltd. Industry: Biotechnology and Healthcare Period: Q4 2025 Basic Earnings Per Share: NT$18.14 Operating Revenue: NT$20.509 billion Net Profit After Tax: NT$4.720 billion

FACT BOX

Source: PR Times
Category: 調查

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　Dec 1, 2025 9:00 AM — Distributor PR Times
Collected　Apr 7, 2026 8:00 AM
AI structured & analyzed　Apr 8, 2026 12:20 AM
Desk-reviewed & published　Dec 1, 2025 9:00 AM

FAQ

What is Lotus Pharmaceutical's stock code?

Lotus Pharmaceutical's stock code is 1795.

What were the key financial highlights for Lotus Pharmaceutical in Q4 2025?

In Q4 2025, Lotus Pharmaceutical reported a basic EPS of NT$18.14, operating revenue of NT$20.509 billion, and a net profit after tax of NT$4.720 billion.

What industry does Lotus Pharmaceutical operate in?

Lotus Pharmaceutical operates in the biotechnology and healthcare industry.

Cite this article — HOW TO CITE

Washin AI News Desk“Lotus Pharmaceutical Co., Ltd. (1795) Reports Strong Q4 2025 Earnings with EPS of NT$18.14”AI News by Washin Village（和心村）, Dec 1, 2025. https://aeo.washinmura.jp/ai/%E7%BE%8E%E6%99%82%E5%8C%96%E5%AD%B8%E8%A3%BD%E8%97%A5%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8/en/news/2026-04-11-lotus-pharmaceutical-co-ltd-2025-q4-eps-nt-18-14

AI CRAWLER ACTIVITY

as of Jun 29, 2026

AI crawler visits to this article (cumulative)133 bots

Site-wide cumulative

ClaudeBot

bot_visits_summary

4254k

last Jun 29, 2026

GPTBot

bot_visits_summary

2686k

last Jun 29, 2026

Google AI

bot_visits_summary

1786k

last Jun 29, 2026

Bingbot

bot_visits_summary

1687k

last Jun 29, 2026

Googlebot

bot_visits_summary

1297k

last Jun 29, 2026

Meta AI

bot_visits_summary

590k

last Jun 29, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 美時化學製藥股份有限公司 Back to newsroom (13)

Copied